CUBICIN Side Effects

6844571-4 | Epstein-barr Virus Infection, Hypothalamo-pituitary Disorder, Transplant Failure
on Jul 02, 2010 Male patient from GERMANY , 65 years of age, weighting 205.0 lb, was diagnosed with infection (What is infection?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: epstein-barr virus infection, hypothalamo-pituitary disorder, transplant failure. Cubicin dosage: . During the same period patient was treated with CICLOSPORIN (View Ciclosporin Review and Ciclosporin Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6844569-6 | Antimicrobial Susceptibility Test Resistant, Staphylococcal Bacteraemia, Thrombophlebitis Superficial, Venous Thrombosis
Patient was taking Cubicin (View Usage). Patient had the following side effects: antimicrobial susceptibility test resistant, staphylococcal bacteraemia, thrombophlebitis superficial, venous thrombosis on Jul 01, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, weighting 163.1 lb, was diagnosed with staphylococcal bacteraemia, atrial fibrillation (What is atrial fibrillation?), depression (What is depression?) and. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ). Patient was hospitalized.

6822924-8 | Headache, Hypertensive Crisis, Pallor, Tachycardia, Tachypnoea, Tremor
Adverse event was reported on Jun 23, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with sepsis (What is sepsis?) and. Location: GERMANY , 81 years of age, After Cubicin was administered, patient had the following side effects: headache (What is headache?), hypertensive crisis, pallor, tachycardia, tachypnoea, tremor. During the same period patient was treated with AMINO ACIDS (View Amino Acids Review and Amino Acids Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), INSULIN (View Insulin Review and Insulin Label ).

6822920-0 | Antimicrobial Susceptibility Test Resistant, Aortic Valve Stenosis, Arthritis Bacterial, Blood Disorder, Endocarditis, Pathogen Resistance, Thrombocytopenia
on Jun 23, 2010 Male patient from UNITED KINGDOM , 82 years of age, was diagnosed with enterococcal infection, endocarditis (What is endocarditis?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: antimicrobial susceptibility test resistant, aortic valve stenosis, arthritis bacterial, blood disorder, endocarditis (What is endocarditis?), pathogen resistance, thrombocytopenia. Cubicin dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).


6809368-X | Antimicrobial Susceptibility Test Resistant, Renal Failure Chronic, Staphylococcal Sepsis
on Jun 15, 2010 Female patient from UNITED KINGDOM , 81 years of age, was diagnosed with soft tissue infection, staphylococcal bacteraemia and was treated with Cubicin (View Usage). Patient had the following side effects: antimicrobial susceptibility test resistant, renal failure chronic, staphylococcal sepsis. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

6791188-6 | Antimicrobial Susceptibility Test Resistant, Aortic Valve Stenosis, Arthritis Bacterial, Endocarditis, Platelet Count Decreased
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: antimicrobial susceptibility test resistant, aortic valve stenosis, arthritis bacterial, endocarditis (What is endocarditis?), platelet count decreased on Jun 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 82 years of age, was diagnosed with enterococcal infection and. Cubicin dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6774037-1 | Confusional State
Adverse event was reported on Jun 14, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with cellulitis staphylococcal and. Location: UNITED STATES , 69 years of age, weighting 230.0 lb, Patient experienced the following unwanted or unexpected effects: confusional state. During the same period patient was treated with INVANZ (View Invanz Review and Invanz Label ). Patient was hospitalized.

6767115-4 | Balance Disorder, Confusional State, Dizziness, Fatigue, Mental Status Changes
on Jun 11, 2010 Male patient from UNITED STATES , 80 years of age, weighting 187.8 lb, was diagnosed with staphylococcal bacteraemia and was treated with Cubicin (View Usage). Patient had the following side effects: balance disorder, confusional state, dizziness (What is dizziness?), fatigue, mental status changes. Cubicin dosage: 500mg Every 24 Hours Iv Drip.

6760732-7 | Convulsion, Gait Disturbance, Mental Status Changes, Muscle Spasms, Visual Acuity Reduced
on May 27, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with secondary progressive multiple sclerosis and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: convulsion, gait disturbance, mental status changes, muscle spasms, visual acuity reduced. Cubicin dosage: .

6760731-5 | Loss Of Consciousness, Rash
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, rash (What is rash?) on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Cubicin dosage: . Patient was hospitalized.

6760730-3 | Weight Decreased
Adverse event was reported on May 28, 2010 by a Female patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with infection (What is infection?), pain (What is pain?) and. Location: UNITED STATES , 67 years of age, weighting 129.0 lb, Patient had the following side effects: weight decreased. During the same period patient was treated with INVANZ (View Invanz Review and Invanz Label ), TIGECYCLINE (View Tigecycline Review and Tigecycline Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MORPHINE (View Morphine Review and Morphine Label ), TYLENOL PM /01088101/ (View Tylenol Pm /01088101/ Review and Tylenol Pm /01088101/ Label ).

6754045-7 | Aneurysm Ruptured
on May 25, 2010 Female patient from INDIA , 22 years of age, weighting 108.0 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: aneurysm ruptured. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

6754042-1 | Speech Disorder
on May 26, 2010 Male patient from UNITED STATES , 69 years of age, weighting 230.0 lb, was diagnosed with cellulitis staphylococcal and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: speech disorder. Cubicin dosage: . During the same period patient was treated with INVANZ (View Invanz Review and Invanz Label ). Patient was hospitalized.

6754041-X | Shock
Patient was taking Cubicin (View Usage). Patient had the following side effects: shock on May 20, 2010 from INDIA Additional patient health information: Male patient , 54 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Cubicin dosage: .

6754039-1 | Laryngeal Oedema, Respiratory Failure
Adverse event was reported on May 19, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with wound dehiscence and. Location: ITALY , 45 years of age, After Cubicin was administered, patient had the following side effects: laryngeal oedema, respiratory failure.

6750394-7 | Abscess, Cellulitis, Multi-organ Failure, Septic Shock, Staphylococcal Infection
on May 17, 2010 Male patient from GERMANY , 57 years of age, weighting 266.8 lb, was diagnosed with abscess (What is abscess?), cellulitis (What is cellulitis?), sepsis (What is sepsis?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), cellulitis (What is cellulitis?), multi-organ failure, septic shock, staphylococcal infection (What is staphylococcal infection?). Cubicin dosage: .

6745545-4 | Chills, Hyperthermia, Myalgia
on May 14, 2010 Female patient from VENEZUELA , 44 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Cubicin (View Usage). Patient had the following side effects: chills, hyperthermia, myalgia. Cubicin dosage: .

6741106-1 | Abdominal Pain, Constipation, Embolism, Faeces Discoloured, Fatigue, Hepatic Failure, Jaundice, Pyrexia, Urine Colour Abnormal
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), embolism, faeces discoloured, fatigue, hepatic failure, jaundice (What is jaundice?), pyrexia, urine colour abnormal on May 11, 2010 from VENEZUELA Additional patient health information: Female patient , 68 years of age, was diagnosed with skin infection, soft tissue infection and. Cubicin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ). Patient was hospitalized.

6740450-1 | Bronchopneumonia, Cardio-respiratory Arrest, Mitral Valve Incompetence, Pulmonary Hypertension
Adverse event was reported on May 10, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with device related infection and. Location: SPAIN , 81 years of age, Patient experienced the following unwanted or unexpected effects: bronchopneumonia, cardio-respiratory arrest, mitral valve incompetence, pulmonary hypertension (What is pulmonary hypertension?). Patient was hospitalized.

6735523-3 | Interstitial Lung Disease, Respiratory Distress
on May 13, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with osteomyelitis, cellulitis (What is cellulitis?) and was treated with Cubicin (View Usage). Patient had the following side effects: interstitial lung disease, respiratory distress. Cubicin dosage: . During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ). Patient was hospitalized.

6734425-6 | Eosinophilic Pneumonia
on Mar 06, 2010 Male patient from UNITED STATES , 60 years of age, was diagnosed with post procedural infection and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: eosinophilic pneumonia. Cubicin dosage: 6 Mg/kg;q24h;.

6734419-0 | Anaphylactic Reaction
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction on Feb 05, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 195.3 lb, was diagnosed with abscess (What is abscess?), cellulitis (What is cellulitis?) and. Cubicin dosage: 6 Mg/kg;q24h;iv. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), FLONASE (View Flonase Review and Flonase Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ), ACETONIDE (View Acetonide Review and Acetonide Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ).

6734413-X | Rhabdomyolysis
Adverse event was reported on Nov 26, 2009 by a Female patient taking Cubicin (View Usage) (Dosage: 7.4 Mg/kg;q24h;iv) was diagnosed with staphylococcal abscess, subcutaneous abscess and. Location: UNITED STATES , 49 years of age, weighting 202.8 lb, Patient had the following side effects: rhabdomyolysis. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6734393-7 | Blood Creatine Phosphokinase Increased
on Nov 18, 2009 Female patient from UNITED STATES , 21 years of age, was diagnosed with bacteraemia, off label use, osteomyelitis, staphylococcal infection (What is staphylococcal infection?) and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: blood creatine phosphokinase increased. Cubicin dosage: 8 Mg/k;q48h;. During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ).

6734392-5 | Blood Creatine Phosphokinase Increased, Pain In Extremity
on Nov 12, 2009 Female patient from UNITED STATES , 68 years of age, weighting 198.4 lb, was diagnosed with cellulitis (What is cellulitis?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, pain in extremity. Cubicin dosage: 5.55 Mg/kg;q24h;iv. During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTIVIT (View Multivit Review and Multivit Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), SEED OIL (View Seed Oil Review and Seed Oil Label ), VITAMIN B COMPLEX TAB (View Vitamin B Complex Tab Review and Vitamin B Complex Tab Label ).

6734391-3 | Blood Creatine Phosphokinase Increased, Myalgia
Patient was taking Cubicin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, myalgia on Nov 03, 2009 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cellulitis and. Cubicin dosage: 4.5 Mg/kg; ;iv. During the same period patient was treated with ERTAPENEM (View Ertapenem Review and Ertapenem Label ). Patient was hospitalized.

6734383-4 | Antibiotic Resistant Staphylococcus Test Positive, Antimicrobial Susceptibility Test Resistant, Endocarditis
Adverse event was reported on Sep 30, 2009 by a Male patient taking Cubicin (View Usage) (Dosage: 8 Mg/kg;) was diagnosed with endocarditis (What is endocarditis?) and. Location: UNITED STATES , 70 years of age, After Cubicin was administered, patient had the following side effects: antibiotic resistant staphylococcus test positive, antimicrobial susceptibility test resistant, endocarditis (What is endocarditis?).

6734382-2 | Eosinophilic Pneumonia
on Sep 24, 2009 Male patient from UNITED STATES , 60 years of age, was diagnosed with osteomyelitis, staphylococcal infection (What is staphylococcal infection?) and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia. Cubicin dosage: . Patient was hospitalized.

6724840-9 | Pain
on May 13, 2010 Male patient from UNITED STATES , 51 years of age, weighting 172.0 lb, was diagnosed with subcutaneous abscess and was treated with Cubicin (View Usage). Patient had the following side effects: pain (What is pain?). Cubicin dosage: 800mg Daily Iv Bolus. Patient was hospitalized and became disabled.

6722492-5 | Chills, Hyperthermia, Myalgia
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: chills, hyperthermia, myalgia on May 07, 2010 from VENEZUELA Additional patient health information: Female patient , 44 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Cubicin dosage: .

6722099-X | Eosinophilic Pneumonia, Weaning Failure
Adverse event was reported on May 04, 2010 by a Female patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with central nervous system infection, wound infection and. Location: UNITED STATES , 81 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: eosinophilic pneumonia, weaning failure. During the same period patient was treated with CEFEPIME (View Cefepime Review and Cefepime Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ACETAMINOPHEN W/ PROPOXYPHENE HCL (View Acetaminophen W/ Propoxyphene Hcl Review and Acetaminophen W/ Propoxyphene Hcl Label ), CALCIUM CARBONATE W/VITAMIN D NOS (View Calcium Carbonate W/vitamin D Nos Review and Calcium Carbonate W/vitamin D Nos Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ). Patient was hospitalized.

6721902-7 | Hepatic Failure
on May 04, 2010 Female patient from VENEZUELA , 59 years of age, was treated with Cubicin (View Usage). Patient had the following side effects: hepatic failure. Cubicin dosage: .

6721891-5 | Metabolic Syndrome
on Apr 29, 2010 Male patient from BRAZIL , 51 years of age, weighting 144.8 lb, was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: metabolic syndrome (What is metabolic syndrome?). Cubicin dosage: .

6721840-X | Antimicrobial Susceptibility Test Resistant, Staphylococcal Bacteraemia, Thrombophlebitis Superficial, Venous Thrombosis
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: antimicrobial susceptibility test resistant, staphylococcal bacteraemia, thrombophlebitis superficial, venous thrombosis on Apr 30, 2010 from UNITED STATES Additional patient health information: Male patient , 84 years of age, weighting 163.1 lb, was diagnosed with staphylococcal bacteraemia and. Cubicin dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

6721832-0 | Staphylococcal Infection
Adverse event was reported on Apr 27, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with endocarditis (What is endocarditis?) and. Location: UNITED KINGDOM , 62 years of age, Patient had the following side effects: staphylococcal infection (What is staphylococcal infection?).

6710371-9 | Septic Shock
on Apr 24, 2010 Female patient from INDIA , 70 years of age, weighting 132.3 lb, was diagnosed with sepsis (What is sepsis?) and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: septic shock. Cubicin dosage: .

6710366-5 | Torsade De Pointes, Ventricular Fibrillation
on Apr 27, 2010 Male patient from UNITED STATES , 71 years of age, weighting 151.5 lb, was diagnosed with osteomyelitis and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: torsade de pointes, ventricular fibrillation. Cubicin dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), COLACE (View Colace Review and Colace Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

6702746-9 | Acute Respiratory Distress Syndrome, Septic Shock
Patient was taking Cubicin (View Usage). Patient had the following side effects: acute respiratory distress syndrome, septic shock on Apr 16, 2010 from INDIA Additional patient health information: Female patient , 70 years of age, weighting 132.3 lb, was diagnosed with soft tissue infection, decubitus ulcer and. Cubicin dosage: .

6702745-7 | Acute Myocardial Infarction
Adverse event was reported on Apr 14, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with cellulitis (What is cellulitis?), skin infection and. Location: UNITED KINGDOM , 71 years of age, weighting 260.1 lb, After Cubicin was administered, patient had the following side effects: acute myocardial infarction. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

6690807-2 | Bronchopneumonia, Cardio-respiratory Arrest, Mitral Valve Incompetence, Pulmonary Hypertension
on Apr 08, 2010 Male patient from SPAIN , 81 years of age, was diagnosed with device related infection and was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopneumonia, cardio-respiratory arrest, mitral valve incompetence, pulmonary hypertension (What is pulmonary hypertension?). Cubicin dosage: . Patient was hospitalized.

6690802-3 | Myositis
on Apr 09, 2010 Female patient from UNITED STATES , 78 years of age, weighting 171.1 lb, was diagnosed with arthritis infective, hypercholesterolaemia, hypothyroidism, hypertension, depression (What is depression?), neoplasm malignant and was treated with Cubicin (View Usage). Patient had the following side effects: myositis (What is myositis?). Cubicin dosage: . During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), FEMARA (View Femara Review and Femara Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ). Patient was hospitalized.

6690796-0 | Septic Shock
Patient was taking Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: septic shock on Apr 06, 2010 from FRANCE Additional patient health information: Male patient , 43 years of age, weighting 112.4 lb, was diagnosed with staphylococcal infection (What is staphylococcal infection?), device related infection and. Cubicin dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

6675416-3 | Hepatitis, Multi-organ Disorder, Septic Shock
Adverse event was reported on Apr 01, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with device related infection and. Location: INDIA , 65 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), multi-organ disorder, septic shock. During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ).

6675413-8 |
on Apr 02, 2010 Male patient from FRANCE , 43 years of age, weighting 112.4 lb, was diagnosed with staphylococcal bacteraemia, endocarditis staphylococcal and was treated with Cubicin (View Usage). . Cubicin dosage: . During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

6675411-4 | Acute Myeloid Leukaemia, Malignant Neoplasm Progression, Multi-organ Failure
on Mar 29, 2010 Male patient from GERMANY , 60 years of age, weighting 88.18 lb, was diagnosed with infection (What is infection?), sepsis (What is sepsis?) and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: acute myeloid leukaemia, malignant neoplasm progression, multi-organ failure. Cubicin dosage: .

6675410-2 | Blood Lactic Acid Increased, Cardiopulmonary Failure, Enterococcal Sepsis, Malignant Neoplasm Progression, Pneumonia Viral
Patient was taking Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, cardiopulmonary failure, enterococcal sepsis, malignant neoplasm progression, pneumonia viral on Mar 29, 2010 from GERMANY Additional patient health information: Female patient , 54 years of age, weighting 154.3 lb, was diagnosed with graft infection and. Cubicin dosage: .

6675245-0 | Acute Graft Versus Host Disease In Intestine, Acute Graft Versus Host Disease In Liver, Device Related Infection, Malignant Neoplasm Progression, Staphylococcal Infection
Adverse event was reported on Mar 29, 2010 by a Male patient taking Cubicin (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: GERMANY , 50 years of age, weighting 198.4 lb, Patient had the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, device related infection, malignant neoplasm progression, staphylococcal infection (What is staphylococcal infection?).

6675243-7 | Cardiac Arrest, Endocarditis, Enterococcal Bacteraemia, Lower Respiratory Tract Infection, Urinary Tract Infection
on Jan 21, 2010 Male patient from AUSTRALIA , 76 years of age, was diagnosed with enterococcal bacteraemia and was treated with Cubicin (View Usage). After Cubicin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), endocarditis (What is endocarditis?), enterococcal bacteraemia, lower respiratory tract infection, urinary tract infection (What is urinary tract infection?). Cubicin dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), TIOTROPIUM (View Tiotropium Review and Tiotropium Label ).

6675226-7 | Opiates Positive
on Apr 02, 2010 Male patient from UNITED STATES , weighting 6.83 lb, was treated with Cubicin (View Usage). Patient experienced the following unwanted or unexpected effects: opiates positive. Cubicin dosage: . Patient was hospitalized.

6675225-5 | Breech Presentation, Opiates Positive
Patient was taking Cubicin (View Usage). Patient had the following side effects: breech presentation, opiates positive on Apr 02, 2010 from UNITED STATES Additional patient health information: Female patient , 24 years of age, weighting 154.3 lb, was diagnosed with endocarditis (What is endocarditis?), staphylococcal bacteraemia and. Cubicin dosage: . During the same period patient was treated with OXYCODONE (View Oxycodone Review and Oxycodone Label ), DEMEROL (View Demerol Review and Demerol Label ), RITALIN (View Ritalin Review and Ritalin Label ), ZOSYN (View Zosyn Review and Zosyn Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), NAFCILLIN (View Nafcillin Review and Nafcillin Label ). Patient was hospitalized.